SB 969·MD·senate
Health Insurance - Lyme Disease and Related Tick-Borne Illnesses - Long-Term Antibiotic Treatment
In CommitteeFiled Feb 13, 2026
Sponsor: Mautz
Latest Action
In the Senate - Hearing 3/13 at 1:00 p.m.
Mar 13, 2026
Summary
The bill obligates certain insurers, nonprofit health service plans, and health maintenance organizations to pay for the entire course of long‑term antibiotic treatment when a licensed doctor orders it for Lyme disease or a related tick‑borne illness. It also forbids these entities from setting quantity caps or denying coverage because the treatment is labeled experimental. The requirements would apply to policies issued or renewed on or after Jan. 1, 2027.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when SB 969 changes status, plus AI-powered summaries and stage predictions.
Sign up free